Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy: A Prospective Randomized Trial

NCT03383003 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT03383003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03383003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy: A Prospective Randomized Trial
Lead sponsor
Chang Gung Memorial Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2016
Completion date
May 1, 2018
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection